Towards tumor therapy with interferons, part II. Interferons: in vivo effects.
D000818:Animals; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D002689:Chlamydia; D005347:Fibroblasts; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D007962:Leukocytes; D051379:Mice; D009101:Multiple Myeloma / Q000188:drug therapy; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009381:Neoplasms, Radiation-Induced / Q000188:drug therapy; D012516:Osteosarcoma / Q000188:drug therapy; D010212:Papilloma / Q000188:drug therapy; D010962:Plasmodium berghei; D011817:Rabbits; D014412:Tumor Virus Infections / Q000188:drug therapy
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D007372:Interferons